CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net income	$ 25,104	$ 23,318
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(2,362)	(2,129)
Depreciation and amortization	3,150	2,974
Write down of other real estate, net of gain on sale	(165)	(222)
Amortization of core deposit premium and mortgage servicing rights	2,404	4,601
Net amortization of investment securities	5,826	5,801
Share-based compensation	412	635
Net loss on investment securities	1,640	0
Net gain on sales of residential loans	(2,396)	(3,311)
Proceeds from sales of loans held for sale	168,624	193,848
Originations of loans held for sale	(147,635)	(186,349)
Equity in earnings of unconsolidated subsidiaries	(212)	(274)
Net increase in cash surrender value of bank-owned life insurance	(2,170)	(1,994)
Deferred income taxes	13,648	12,398
Net tax benefits from share-based compensation	583	0
Net change in other assets and liabilities	(8,279)	1,373
Net cash provided by operating activities	58,172	50,669
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	86,372	81,894
Proceeds from sales of investment securities available for sale	96,019	0
Purchases of investment securities available for sale	(253,372)	(46,215)
Proceeds from maturities of and calls on investment securities held to maturity	12,715	13,289
Net loan proceeds (originations)	(17,715)	(115,771)
Purchases of loan portfolios	(50,725)	(77,702)
Proceeds from sale of other real estate	102	1,789
Proceeds from bank-owned life insurance	1,710	1,283
Purchases of premises and equipment	(4,144)	(2,183)
Net return of capital from unconsolidated subsidiaries	455	412
Contributions to unconsolidated subsidiaries	0	(5)
Net (purchases) proceeds from redemption of FHLB stock	5,080	(6,612)
Net cash used in investing activities	(123,503)	(149,821)
Cash flows from financing activities:
Net increase (decrease) in deposits	278,181	(28,297)
Net (decrease) increase in short-term borrowings	(135,000)	157,000
Cash dividends paid on common stock	(10,432)	(8,734)
Repurchases of common stock and other related costs	(11,208)	(10,544)
Net proceeds from issuance of common stock and stock option exercises	0	199
Net cash provided by financing activities	121,541	109,624
Net increase in cash and cash equivalents	56,210	10,472
Cash and cash equivalents at beginning of period	84,341	80,194
Cash and cash equivalents at end of period	140,551	90,666
Cash received during the period for:
Income taxes	5,461	3,986
Supplemental disclosure of non-cash investing and financing activities:	4,000	0
Transfer of Portfolio Loans and Leases to Other Real Estate	154	637
Cash received during the period for:
Income taxes	0	1,605
Supplemental disclosure of non-cash investing and financing activities:
Net change in common stock held by directors’ deferred compensation plan	$ 341	$ 99

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.